JCOVDEN™ (COVID-19 Vaccine (Ad26.COV2-S [recombinant])) is indicated for active immunization for the prevention of coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 virus in individuals 18 years of age and older. JCOVDEN must be injected intramuscularly only. Drug Identification Number (DIN): 02513153.
To monitor vaccine safety, the Public Health Agency of Canada collects information on serious and unexpected reports of adverse events following immunization. Should you wish to report an adverse event following immunization, please complete the Adverse Events Following Immunization (AEFI) Form or call: